CLINICAL-EXPERIENCE WITH DOXAZOSIN IN GENERAL MEDICAL-PRACTICE

被引：15

作者：

ROSENTHAL, J

机构：

来源：

AMERICAN HEART JOURNAL | 1988年 / 116卷 / 06期

关键词：

D O I：

10.1016/0002-8703(88)90224-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1748 / 1757

页数：10

共 8 条

[1]

CONRAD KA, 1988, IN PRESS EUR J CLIN

[2] CLINICAL-PHARMACOLOGY OF DOXAZOSIN IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].

CUBEDDU, LX ;

FUENMAYOR, N ;

CAPLAN, N ;

FERRY, D .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (04) :439-449

[3] EFFECT OF ALPHA-BLOCKER AND BETA-BLOCKER THERAPY ON BLOOD-LIPIDS - EUROPEAN-EXPERIENCE [J].

LEREN, P .

AMERICAN JOURNAL OF MEDICINE, 1984, 76 (2A) :67-71

[4]

MOSER M, 1985, J CARDIOVASC PHARM, V7, pS109

[5] ADRENERGIC EFFECTS ON PLASMA-LIPOPROTEIN METABOLISM - SPECULATION ON MECHANISMS OF ACTION [J].

SACKS, FM ;

DZAU, VJ .

AMERICAN JOURNAL OF MEDICINE, 1986, 80 (2A) :71-81

[6] EFFECTS OF PRAZOSIN AND ALPHAMETHYLDOPA ON BLOOD-LIPIDS AND LIPOPROTEINS IN HYPERTENSIVE PATIENTS [J].

VELASCO, M ;

SILVA, H ;

FELDSTEIN, E ;

PELLICER, R ;

MORILLO, J ;

URBINAQUINTANA, A ;

HERNANDEZPIERETTI, O .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (05) :513-516

[7] ANTIHYPERTENSIVE TREATMENT AND SERUM-LIPOPROTEINS [J].

WEIDMANN, P ;

UEHLINGER, DE ;

GERBER, A .

JOURNAL OF HYPERTENSION, 1985, 3 (04) :297-306

[8] CORONARY RISK PREDICTION IN ADULTS (THE FRAMINGHAM HEART-STUDY) [J].

WILSON, PWF ;

CASTELLI, WP ;

KANNEL, WB .

AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (14) :G91-G94

← 1 →